What Scott Gottlieb’s Resignation Means for Medical Device Investors How to navigate a sudden leadership vacuum at the FDA Read More Equity AnalysisChristopher WareMarch 7, 2019FDA, Regulatory Strategy, Medical Device, Venture Capital, Investing